No Matter the Money, I Want the Vaccine in December

Many countries are ordering in advance to get the corona vaccine in advance. The Trump administration has announced many large investments to get vaccinated. The country has signed a 2 billion US dollar deal with vaccine maker Pfizer and Bio N Tech to get 100 million doses of the vaccine by December.

The ‘New York Times’ reports that Pfizer has been contracted under the White House's ‘Rap Speed ​​Project’ as part of a rapid vaccination initiative. It is expected that the work of making and marketing the vaccine will be faster. So far, the United States has invested in six vaccines to increase vaccine production and innovation capabilities.

Like the United States, Europe is making various efforts to get vaccinated. Germany has already bought a 23 percent stake in the country's CureVac. US President Donald Trump has tried to drag the organization to the United States. In addition, Europe has announced to spend 8 billion dollar on vaccine research.

The ‘New York Times’ reports that no vaccines have been approved. It is unknown at this time what he will do after leaving the post. However, the United States has agreed with Pfizer to ensure priority for vaccination. Pfizer authorities say they will produce 100 million doses of the vaccine by December if the vaccine proves effective.

According to the agreement, Pfizer's vaccine will cost 20 US dollar per dose. They will receive doses of the first batch of vaccines. However, US citizens will receive the vaccine free of charge. However, the vaccine must be approved by the Food and Drug Administration. The US condition is that they will pay only if the vaccine is safe and understands 100 million doses.

According to Pfizer, large-scale testing of the vaccine has begun this month to prove it is safe and effective. Regulators will review its results by October. But so far nothing is certain.

Pfizer and Bio n Tech, as well as Oxford University, announced the results of the initial phase of their vaccination. They claim that their vaccine has been shown to be safe in the patient's body and has shown an immune response. The Pfizer vaccine also showed a high T-cell response to fight coronavirus.

Earlier, on July 1, Pfizer reported positive results from an experimental vaccine against COVID-19. They claim that it increases immunity in healthy people. It has produced antibodies against the SARS-Cov-2 virus. These antibodies contain antibodies that are effective in neutralizing or neutralizing viruses. The neutralizing antibodies produced in the body of a person recovering from Covid-19 disease are 1.8 to 2.8 times higher. However, if it is given in high doses, other side effects including fever occur.

The company is showing enough confidence to make a successful vaccine. In an interview with Time Online, Albert Borla, Pfizer's chief executive officer (CEO), said they hoped to get approval from the Food and Drug Administration for their vaccine by next October. They will know the effectiveness of the vaccine in September.

More than 150 vaccines are being developed and tested worldwide. There are currently 23 vaccines being administered experimentally to humans, including the Modern and AstraZeneca vaccines. However, experts warn that it takes 12 to 18 months to develop a safe and effective vaccine.